These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26192706)

  • 1. Recent Advancements in Cardiovascular Gene Therapy and Vascular Biology.
    Laakkonen JP; Ylä-Herttuala S
    Hum Gene Ther; 2015 Aug; 26(8):518-24. PubMed ID: 26192706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vectors for gene therapy of cardiovascular disease.
    Dedieu JF; Mahfoudi A; Le Roux A; Branellec D
    Curr Cardiol Rep; 2000 Jan; 2(1):39-47. PubMed ID: 10980871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation.
    Rincon MY; VandenDriessche T; Chuah MK
    Cardiovasc Res; 2015 Oct; 108(1):4-20. PubMed ID: 26239654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system.
    Zacchigna S; Zentilin L; Giacca M
    Circ Res; 2014 May; 114(11):1827-46. PubMed ID: 24855205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel vectors for in vivo gene delivery to vascular tissue.
    White K; Nicklin SA; Baker AH
    Expert Opin Biol Ther; 2007 Jun; 7(6):809-21. PubMed ID: 17555367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing gene delivery vectors for cardiovascular gene therapy.
    Baker AH
    Prog Biophys Mol Biol; 2004; 84(2-3):279-99. PubMed ID: 14769440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular gene therapy: current status and therapeutic potential.
    Gaffney MM; Hynes SO; Barry F; O'Brien T
    Br J Pharmacol; 2007 Sep; 152(2):175-88. PubMed ID: 17558439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy.
    March KL; Madison JE; Trapnell BC
    Hum Gene Ther; 1995 Jan; 6(1):41-53. PubMed ID: 7703286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy prospects--intranasal delivery of therapeutic genes.
    Podolska K; Stachurska A; Hajdukiewicz K; Małecki M
    Adv Clin Exp Med; 2012; 21(4):525-34. PubMed ID: 23240459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications.
    Katz MG; Fargnoli AS; Williams RD; Bridges CR
    Hum Gene Ther; 2013 Nov; 24(11):914-27. PubMed ID: 24164239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-selective viral gene delivery vectors for the vasculature.
    Baker AH; Kritz A; Work LM; Nicklin SA
    Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for cardiovascular disease: perspectives and potential.
    Bradshaw AC; Baker AH
    Vascul Pharmacol; 2013 Mar; 58(3):174-81. PubMed ID: 23142171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral vector delivery of neurotrophic factors for Parkinson's disease therapy.
    Kelly MJ; O'Keeffe GW; Sullivan AM
    Expert Rev Mol Med; 2015 May; 17():e8. PubMed ID: 25997719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral vectors for gene therapy of heart disease.
    Higuchi K; Medin JA
    J Cardiol; 2007 Jan; 49(1):1-11. PubMed ID: 17269208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-primate lentiviral vectors.
    Poeschla EM
    Curr Opin Mol Ther; 2003 Oct; 5(5):529-40. PubMed ID: 14601523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
    Serguera C; Bemelmans AP
    Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vectors and cardiovascular diseases: a genetic tool for manipulating cardiomyocyte differentiation and function.
    Di Pasquale E; Latronico MV; Jotti GS; Condorelli G
    Gene Ther; 2012 Jun; 19(6):642-8. PubMed ID: 22378345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latest development in viral vectors for gene therapy.
    Lundstrom K
    Trends Biotechnol; 2003 Mar; 21(3):117-22. PubMed ID: 12628368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Developments in gene delivery vectors for ocular gene therapy].
    Khabou H; Dalkara D
    Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent highlights and advances in cardiac gene therapy.
    Oh JG; Ishikawa K
    Discov Med; 2019; 28(155):229-235. PubMed ID: 32053763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.